CPIHF yields 12500.00% · PFE yields 6.13%● Live data
📍 CPIHF pulled ahead of the other in Year 1
Combined, CPIHF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CPIHF + PFE for your $10,000?
Champion Technology Holdings Limited, an investment holding company, primarily engages in the trading of gasoil and cultural products, sales of renewable energy systems and related engineering work, software development, and licensing and customization of system products in the People's Republic of China, the United Kingdom, and Germany. The company operates through five segments: Sales of Cultural Products, Sales of Surveillance Equipment, Renewable Energy, Trading for Gasoil and Related Business, and Strategic Investments. It is involved in the sales of cultural products, gasoil, and surveillance equipment; design and sale of renewable energy products and solutions; charters vessels; general system products; and provision of systems and related software licensing services, as well as installation and maintenance services; and payment gateways and Internet of Things services. The company also offers e-shopping, Internet-based, e-commerce, and m-commerce services; invests in and leases properties; advertising and recruitment agency services; and trades in pagers and provides messaging services, as well as telecommunication system and products. In addition, it provides management, documentation, and arrangement and business consultant services; messaging services; and consulting, research and development, and telecommunication services. Further, the company engages in the money lending activities; and investing in listed securities. Champion Technology Holdings Limited is based in Shek Tong Tsui, Hong Kong.
Full CPIHF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.